Novo Nordisk and Eli Lilly are the two leading pharmaceutical companies in this space
Obesity and type 2 diabetes are recognized as comorbidities for low testosterone and sexual dysfunction
North Texas GME Research Forum 2024 Files Download Poster or Presentation (224 KB) Division North Texas Hospital Medical City Weatherford Specialty Internal Medicine Document Type Poster Publication Date 2024 Keywords bariatric surgery, glucagon-like peptide (GLP-1) receptor agonists Disciplines Internal Medicine | Medicine and Health Sciences | Surgical Procedures, Operative Abstract Glucagon-like peptide receptor agonists (GLP-1 RA) are FDA-approved medications for the treatment of type 2 diabetes mellitus, and obesity, and are also beneficial in cardiovascular risk reduction
We also discuss the causes and treatments for common skin conditions, including dandruff, acne, rosacea, eczema, psoriasis, and vitiligo
DNA methylation: an epigenetic mark of cellular memory